It is hypothesized that acquisition of certain mutations drives a malignant cell to “differentiation”; either to astrocytoma by obtaining TP53 and ATRX mutations or to oligodendroglioma by losing 1p and 19q (Ohgaki and Kleihues, 2013). Here, TP53 is linked to oligodendroglioma.